ÂÜÀòÂÒÂ×

Hans Henrik Thrane is an experienced financial executive currently serving as Interim Chief Financial Officer at Fertin Pharma A/S since October 2023. Since July 2014, Hans Henrik Thrane has been the Chairman of the Board at SKY-LIGHT A/S, focusing on transitioning the company away from a traditional family board structure. Previously, Hans Henrik Thrane held the position of Executive Vice President and CFO at Columbus A/S from June 2010 to March 2023, achieving a remarkable 57% ROI for shareholders over 12 years. Other notable roles include Interim CEO at IC Companys A/S and various managerial positions in finance and auditing at leading firms such as Vaekstfonden and Ernst & Young. Hans Henrik Thrane possesses extensive academic credentials, including State Authorized Public Accountant certifications and degrees from Copenhagen Business School and INSEAD, which complement substantial professional achievements throughout a career dedicated to enhancing financial management and organizational performance.